Yoshimasa Nobeyama

Outcomes of Curative‐Intent Endoscopic Resection Combined With Adjuvant Immune Checkpoint Inhibition for Resectable Sinonasal Mucosal Melanoma

ABSTRACT Background Evidence for adjuvant immune checkpoint inhibitor (ICI) therapy after curative‐intent resection of sinonasal mucosal melanoma (SNMM) is limited. Methods We retrospectively reviewed 11 patients with resectable N0M0 SNMM who underwent curative‐intent endoscopic...